Taken together these findings suggest that IGF1/IGF1R axis engages ERK1/2 and AKT signaling to trigger the activation of HIF-1α/GPER/VEGF transduction pathway in breast tumor microenvironment. Here, MAPK3 is linked to breast neoplasm.